The Form 4 filing, an SEC report of insider trades, was filed on November 12, 2026. It covers a sale on November 10, 2026. John Howard Goss Jr. is listed as senior vice president and president of Sally Beauty.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-10 |
| Date of Latest Transaction | 2026-11-10 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 50,000 |
| Price | $20.00 |
| Total Transaction Value | $1,000,000.00 |
| Insider | |
| Ticker Symbol | SBH |
| Company | Sally Beauty Holdings, Inc. |
| Insider Name | Goss John Howard JR |
| Insider Title | SVP & President Sally Beauty |
| Sector - Industry | Consumer Cyclical - Specialty Retail |
| Holdings | |
| Total Shares Owned After Transaction | 65,484 |
| Position Size Change | 43.30% |
| Filing | |
| Filing Date | 2026-11-12 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a sale of SBH shares, reported under transaction code S. The record lists one transaction involving 50,000 shares.
What was the average price of the transaction?
The reported average price was $20.00 per share.
How did this transaction affect the insider's holdings?
John Howard Goss Jr. sold 50,000 shares and reported owning 65,484 shares afterward. These figures put his reported share count before the sale at 115,484. He sold 43.30% of that earlier balance.
What's the total transaction value?
The total reported sale value was $1,000,000.00. This amount covers all 50,000 shares in the one reported transaction.
Are there any special circumstances around this transaction?
The available filing information includes a reference to a Rule 10b5-1 trading plan. Such plans set trading instructions in advance. The details do not show whether the reference applies to this sale specifically or to the filing as a whole. Footnote text was not provided to clarify that point. The plan's adoption date and trading schedule remain unknown. The reference alone does not establish that the plan met the rule's requirements.
For research purposes only; not investment advice.